In a first-of-its-kind study, research from the University of Vermont Cancer Center has linked phthalates, commonly called the "everywhere chemical," to higher incidence of specific childhood cancers.
Mar 16, 2022
0
31
Antibiotic-resistant bacterial infections are difficult to treat and cause more than a million annual deaths worldwide, especially in hospitalized patients with pneumonia, bloodstream infections, urinary tract infections, ...
Mar 9, 2022
0
33
More than one-quarter of infections in Canada fail to clear up when people are treated with standard antibiotics. This failure occurs because of a phenomenon called antimicrobial resistance (also called AMR), where bacteria ...
Mar 2, 2022
0
1
A new modelling study suggests that when patients who inject opioids continue an antibiotic treatment for infective endocarditis outside of the hospital, they experience better long-term health outcomes than patients who ...
Feb 28, 2022
0
3
The Estonian Microbiome Project, using electronic health data from more than 2500 biobank participants finds long-term antibiotic usage, independent from recent administration, has an impact on the microbiome, partly explaining ...
Feb 15, 2022
0
2
A team of doctors and researchers working at Erasmus Hospital in Belgium has successfully treated an adult woman infected with a drug-resistant bacteria using a combination of bacteriophage therapy and antibiotics. In their ...
When you open a carton of Neapolitan ice cream, how do you scoop? Maybe you grab some chocolate and strawberry together, or maybe you eat one flavor at a time. The three flavors are in there to satisfy the variation you need ...
Jan 17, 2022
0
3
If you have a cold, don't ask your doctor for antibiotics—that's the golden rule. They're for bacterial infections, not viral ones. We're told not only that they won't work, but that by using antibiotics when they aren't ...
Jan 5, 2022
0
36
Experts predict that without intervention, the problem of multidrug-resistant bacterial infections could be catastrophic by 2050, killing nearly 10 million people each year.
Nov 24, 2021
0
10
We've waited 20 months for a medicine to blunt the coronavirus, and now two have appeared. Earlier this month, the UK medicines regulator approved molnupiravir, the COVID antiviral developed by Merck and Ridgeback Therapeutics. ...
Nov 12, 2021
0
41
